313 research outputs found
A Study of the \u3cem\u3eWisconsin News Pink Flash\u3c/em\u3e
To show the general content of the Wisconsin News Pink Flash including the space devoted to feature stories, daily features, advertising, and pictures, is the purpose of this thesis. Percentages and averages of the total space devoted to each of the three divisions - features, pictures, and advertising - will be calculated
Prospects of forming ultracold molecules in double-Sigma states by magnetoassociation of alkali-metal atoms with Yb
We explore the feasibility of producing ultracold diatomic molecules with nonzero electric and magnetic dipole moments by magnetically associating two atoms, one with zero electron spin and one with nonzero spin. Feshbach resonances arise through the dependence of the hyperfine coupling on internuclear distance.We survey the Feshbach resonances in diatomic systems combining the nine stable alkali-metal isotopes with those of Yb, focusing on the illustrative examples of RbYb and CsYb. We show that the resonance widths may expressed as a product of physically comprehensible terms in the framework of Fermi’s golden rule. The resonance widths depend strongly on the background scattering length, which may be adjusted by selecting the Yb isotope, and on the hyperfine coupling constant and the magnetic field. In favorable cases the resonances may be over 100 mG wide
Magnetically Tunable Feshbach Resonances in Ultracold Li-Yb Mixtures
We investigate the possibility of forming Li+Yb ultracold molecules by magnetoassociation in mixtures of ultracold atoms. We find that magnetically tunable Feshbach resonances exist, but are extremely narrow for even-mass ytterbium isotopes, which all have zero spin. For odd-mass Yb isotopes, however, there is a new mechanism due to hyperfine coupling between the electron spin and the Yb nuclear magnetic moment. This mechanism produces Feshbach resonances for fermionic Yb isotopes that can be more than 2 orders of magnitude larger than for the bosonic counterparts
Voting is Healthcare: Talking Politics With Patients Can Improve Health Outcomes
Introduction: Many healthcare policy-related issues were hot topics during this unprecedented election year. Healthcare workers took it upon themselves to play a major role in the election by introducing voting as a topic of discussion within the patient encounter. At Wayne State University School of Medicine (WSUSOM), the Voting is Healthcare (VIH) Taskforce was created in order for students, residents and faculty to assist patients with voter registration. The Taskforce’s major partner was VotER, a non-profit, non-partisan organization dedicated to helping patients register to vote through a user-friendly and easily-accessible online platform.
Methods: The VIH Taskforce distributed badge-backers with QR codes that patients could scan with their phones to learn more information regarding voter registration, polling location, and absentee voting. Codes were utilized in in-patient settings, clinics, and through tele-health encounters. The VIH Taskforce spearheaded a training session for the WSUSOM community where VotER representatives and local community partners across Michigan spoke.
Results: Per VotER records, the VIH Taskforce and WSUSOM community helped 84 patients vote. Of those patients, 34 were previously unregistered and 50 cast absentee ballots.
Conclusions: In order to increase voter turnout, the VIH Taskforce opened up the patient encounter to include the topic of political advocacy. This is an unprecedented accomplishment, but it is a necessary addition to the social history portion of the visit. Future studies aim to make the link between civic engagement and positive health outcomes explicit
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
peer reviewedaudience: researcher, professionalGermline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide further insights into the possible role of AIP in pituitary tumour pathogenesis, the expression of AIP and AHR was determined by real-time RT-PCR and/or immunohistochemistry (IHC) in a large series of PA (n=103), including 17 with AIP mutations (AIP(mut)). Variable levels of AIP and AHR transcripts were detected in all PA, with a low AHR expression (P<0.0001 versus AIP). Cytoplasmic AIP and AHR were detected by IHC in 84.0 and 38.6% of PA respectively, and significantly correlated with each other (P=0.006). Nuclear AHR was detected in a minority of PA (19.7%). The highest AIP expression was observed in somatotrophinomas and non-secreting (NS) PA, and multivariate analysis in somatotrophinomas showed a significantly lower AIP immunostaining in invasive versus non-invasive cases (P=0.019). AIP expression was commonly low in other secreting PA. AIP immunostaining was abolished in a minority of AIP(mut) PA, with a frequent loss of cytoplasmic AHR and no evidence of nuclear AHR. In contrast, AIP overexpression in a subset of NS PA could be accompanied by nuclear AHR immunopositivity. We conclude that down-regulation of AIP and AHR may be involved in the aggressiveness of somatotrophinomas. Overall, IHC is a poorly sensitive tool for the screening of AIP mutations. Data obtained on AHR expression suggest that AHR signalling may be differentially affected according to PA phenotype
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
Germline mutations of the aryl hydrocarbon receptor (AHR)-interacting protein (AIP) gene confer a predisposition to pituitary adenomas (PA), usually in the setting of familial isolated PA. To provide further insights into the possible role of AIP in pituitary tumour pathogenesis, the expression of AIP and AHR was determined by real-time RT-PCR and/or immunohistochemistry (IHC) in a large series of PA (n=103), including 17 with AIP mutations (AIP(mut)). Variable levels of AIP and AHR transcripts were detected in all PA, with a low AHR expression (P<0.0001 versus AIP). Cytoplasmic AIP and AHR were detected by IHC in 84.0 and 38.6% of PA respectively, and significantly correlated with each other (P=0.006). Nuclear AHR was detected in a minority of PA (19.7%). The highest AIP expression was observed in somatotrophinomas and non-secreting (NS) PA, and multivariate analysis in somatotrophinomas showed a significantly lower AIP immunostaining in invasive versus non-invasive cases (P=0.019). AIP expression was commonly low in other secreting PA. AIP immunostaining was abolished in a minority of AIP(mut) PA, with a frequent loss of cytoplasmic AHR and no evidence of nuclear AHR. In contrast, AIP overexpression in a subset of NS PA could be accompanied by nuclear AHR immunopositivity. We conclude that down-regulation of AIP and AHR may be involved in the aggressiveness of somatotrophinomas. Overall, IHC is a poorly sensitive tool for the screening of AIP mutations. Data obtained on AHR expression suggest that AHR signalling may be differentially affected according to PA phenotype
Integration of design tools and knowledge capture into a CAD system: a case study
onceptual design phase is partially supported by product lifecycle management/computer-aided design (PLM/CAD) systems causing discontinuity of the design information flow: customer needs — functional requirements — key characteristics — design parameters (DPs) — geometric DPs. Aiming to address this issue, it is proposed a knowledge-based approach is proposed to integrate quality function deployment, failure mode and effects analysis, and axiomatic design into a commercial PLM/CAD system. A case study, main subject of this article, was carried out to validate the proposed process, to evaluate, by a pilot development, how the commercial PLM/CAD modules and application programming interface could support the information flow, and based on the pilot scheme results to propose a full development framework
High prevalence of venous thrombotic events in Cushing’s syndrome:data from ERCUSYN and details in relation to surgery
Objective: The aim of this study was to evaluate the prevalence of venous thromboembolism (VTE) in patients included in the European Registry on Cushing's syndrome (ERCUSYN), compare their clinical characteristics with those who did not develop VTE and identify risk factors for VTE. Design: A retrospective observational cohort study. Methods: Data extraction from the registry was taken on February, 7, 2022. At the time there were 2174 patients diagnosed with Cushing's syndrome (CS) and 95 VTEs were reported in the database. Results: Of 95 VTE events 70 (74%) were in pituitary-dependent CS patients, 12 (12.5%) in adrenal-dependant CS, 10 (10.5%) in ectopic CS, and 3 (3%) in CS due to other causes. Sex, 24-hour urinary free cortisol (UFC) value at diagnosis, as well as the number of operations remained statistically significant predictors of VTE. Of patients who were treated with at least one surgery, 12 (13%) VTE occurred before and 80 (87%) after the surgery. Nearly half of these VTEs occurred within six months since the operation (36; 45%). Over half of the centers that reported VTE did not routinely anticoagulate CS patients. Anticoagulation schemes varied widely. Conclusion: Patients with CS have an elevated risk of developing VTE for an extended period of time. From ERCUSYN cohort patients have higher risk for VTE if they need multiple surgeries to treat CS, are males and have high UFC values at the diagnosis of CS. Since there is no agreement on thromboprohpylaxis, a protocol for VTE prevention that is widely adopted appears to be necessary for patients with CS.</p
- …